Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient
Authors:
- Kuldip SinghKSKuldip Singh
- 1 July 1999
- journal article
- case report
- Published by Elsevier in Contraception
- Vol. 60 (1) , 51-53
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The effect of intrauterine levonorgestrel use on the expression of c- JUN, oestrogen receptors, progesterone receptors and Ki-67 in human endometriumMolecular Human Reproduction, 1998
- Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine systemHuman Reproduction, 1998
- Expression of Progesterone Receptor Form A and B mRNAs in Uterine LeiomyomaTumor Biology, 1998
- Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine deviceFertility and Sterility, 1997
- mRNA expression of insulin-like growth factor-I (IGF-I) is suppressed and those of IGF-II and IGF-binding protein-1 are constantly expressed in the endometrium during use of an intrauterine levonorgestrel systemMolecular Human Reproduction, 1997
- Progesterone: A critical role in the pathogenesis of uterine myomasAmerican Journal of Obstetrics and Gynecology, 1995
- Health during prolonged use of levonorgestrel 20μg/d and the Copper TCu 380Ag intrauterine contraceptive devices: a multicenter studyFertility and Sterility, 1994
- Intrauterine progestin induces continuous insulin-like growth factor- binding protein-1 production in the human endometriumThe Journal of Clinical Endocrinology & Metabolism, 1992
- Hysteroscopic surgeryCurrent Opinion in Obstetrics and Gynecology, 1992
- A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagiaAmerican Journal of Obstetrics and Gynecology, 1991